$HAO
Haoxi Health Technology Ltd
CIK:0001954594|SEC Filings
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) |
12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|||||||
| Income Statement [Abstract] | |||||||||
| Revenues | $ 54,828,834 | $ 32,804,336 | $ 48,519,836 | ||||||
| Cost of revenues | 54,199,744 | 31,876,586 | 45,769,459 | ||||||
| Gross profit | 629,090 | 927,750 | 2,750,377 | ||||||
| Operating expenses: | |||||||||
| General and administrative expenses | 8,605,924 | 2,797,933 | 911,531 | ||||||
| Selling and marketing expenses | 78,852 | 50,176 | 41,613 | ||||||
| Research and development expenses | 104,357 | 79,544 | 79,985 | ||||||
| Impairment loss on non-current assets | 1,504,058 | ||||||||
| Total operating expenses | 10,293,191 | 2,927,653 | 1,033,129 | ||||||
| (Loss) income from operations | (9,664,101) | (1,999,903) | 1,717,248 | ||||||
| Other income (loss): | |||||||||
| Interest expense | (52,446) | (45,956) | (41,186) | ||||||
| Interest income | 216,809 | 363,312 | 76,096 | ||||||
| Issuance costs allocated to warrant liability | (919,022) | ||||||||
| Change in fair value of warrant liability | 6,761,462 | ||||||||
| Other income (expense) | 107 | (12,469) | (16,909) | ||||||
| Total other income (loss), net | 164,470 | 6,147,327 | 18,001 | ||||||
| (Loss) income before income taxes | (9,499,631) | 4,147,424 | 1,735,249 | ||||||
| Income tax expense | (36,614) | (270,744) | (443,582) | ||||||
| Net (loss) income | (9,536,245) | 3,876,680 | 1,291,667 | ||||||
| Comprehensive (loss) income | |||||||||
| Net Income (Loss) | (9,536,245) | 3,876,680 | 1,291,667 | ||||||
| Foreign currency translation gain (loss) | 128,846 | (1,133) | 387 | ||||||
| Total comprehensive (loss) income | $ (9,407,399) | $ 3,875,547 | $ 1,292,054 | ||||||
| (Loss) earnings per ordinary share | |||||||||
| Earnings (loss) earnings per share - basic | [2] | $ (386.4) | [1] | $ 4,251.81 | [1] | $ 2,701.53 | |||
| Earnings (loss) earnings per share - diluted | [2] | $ (386.4) | $ 3,385.53 | $ 2,701.53 | |||||
| Denominator: | |||||||||
| Weighted average shares outstanding - basic | 24,680 | 912 | 478 | ||||||
| Diluted (in Shares) | 24,680 | 936 | 478 | ||||||
| |||||||||
Consolidated Balance Sheets - USD ($) |
Jun. 30, 2026 |
Jun. 30, 2025 |
||
|---|---|---|---|---|
| Current Assets | ||||
| Cash and cash equivalents | $ 10,933,108 | $ 8,618,461 | ||
| Accounts receivables, net | 5,944 | 460,272 | ||
| Advances to suppliers, net | 5,745,489 | 5,699,738 | ||
| Prepayments, receivables and other assets, net | 129,286 | 4,826,089 | ||
| Total current assets | 16,813,827 | 19,604,560 | ||
| Non-current assets | ||||
| Investment in convertible bond | 4,652,250 | |||
| Property and equipment, net | 104,169 | 108,899 | ||
| Intangible assets | 1,802,667 | |||
| Operating right-of-use asset | 79,188 | |||
| Total non-current assets | 4,756,419 | 1,990,754 | ||
| Total Assets | 21,570,246 | 21,595,314 | ||
| Current Liabilities | ||||
| Short-term loans | 1,321,411 | 1,307,937 | ||
| Accounts payables | 160,084 | 153,865 | ||
| Advance from customers | 667,566 | 537,646 | ||
| Taxes payable | 1,237,446 | 1,307,270 | ||
| Accrued expenses and other liabilities | 1,027 | |||
| Salary and welfare payable | 24,665 | 32,268 | ||
| Warrant liability | 1,414 | 104,433 | ||
| Operating right-of-use liabilities-current | 79,188 | |||
| Principal Amount | 290,710 | 300,338 | ||
| Long-term accounts payable-current | 26,496 | |||
| Total current liabilities | 3,710,569 | 3,911,561 | ||
| Non-current Liabilities | ||||
| Long-term borrowing | 307,323 | |||
| Total non-current liabilities | 307,323 | |||
| Total Liabilities | 3,710,569 | 4,218,884 | ||
| Commitments and contingencies | ||||
| SHAREHOLDERS’ EQUITY:: | ||||
| Additional paid-in capital | 22,001,505 | 12,814,826 | ||
| Statutory reserves (in Dollars) | 7,318 | |||
| (Accumulated deficit) Retained earnings | (4,943,676) | 4,599,887 | ||
| Accumulated other comprehensive income (loss) | 83,321 | (45,525) | ||
| Total shareholders’ equity | 17,859,677 | 17,376,430 | ||
| Total liabilities and shareholders’ equity | 21,570,246 | 21,595,314 | ||
| Class A Ordinary Shares | ||||
| SHAREHOLDERS’ EQUITY:: | ||||
| Ordinary shares value | [1] | 609,482 | 5,515 | |
| Class B Ordinary Shares | ||||
| SHAREHOLDERS’ EQUITY:: | ||||
| Ordinary shares value | [1] | 101,727 | 1,727 | |
| Related Party | ||||
| Current Liabilities | ||||
| Amount due to related parties | $ 6,246 | $ 62,120 | ||
| ||||